Hematology 1

In the 2020 Hematology 1 special edition of CURE magazine, we highlight what it means to be an everyday hero by living with MPN or helping patients with the disease cope with it.

Targeted therapies have changed the landscape of cancer care, and now, hope for remission is a possibility for certain patients with acute myeloid leukemia with new approved therapies.

Terry White, who has lived with multiple myeloma for more than a decade, offers reassurance to other patients.

Patients with relapsed and resistant diffuse large B-cell lymphoma can look to new treatments beyond tried-and-true chemotherapy.

An expert sheds light on the latest therapies in clinical trials and promising drug combinations to thwart the aggressive disease.

A wave of new targeted therapies expands the options in acute myeloid leukemia.

Newer medications that displace chemotherapy aim directly at mutations in the Bruton tyrosine kinase gene and help patients with CLL live longer.